You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stage I childhood small noncleaved cell lymphoma

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lung Cancer, Metastatic Cancer Trial in Detroit (Cryotherapy (PTC), Prednisone)

Completed
Has Results
  • Lung Cancer
  • Metastatic Cancer
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Oct 29, 2022

Stage IIIB NSCLC AJCC v7, Stage IV NSCLC AJCC v7 Trial in Portland (Laboratory Biomarker Analysis, Paclitaxel, Pharmacological

Completed
  • Stage IIIB Non-Small Cell Lung Cancer AJCC v7
  • Stage IV Non-Small Cell Lung Cancer AJCC v7
  • Laboratory Biomarker Analysis
  • +3 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Sep 14, 2022

Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia, Contiguous Stage II Adult Diffuse Large Cell

Active, not recruiting
  • Adult Grade III Lymphomatoid Granulomatosis
  • +71 more
  • Chicago, Illinois
  • +5 more
Oct 8, 2021

NSCLC, Stage I Trial in Xi'an (Segmentectomy, Lobectomy)

Enrolling by invitation
  • NSCLC, Stage I
  • Segmentectomy
  • Lobectomy
  • Xi'an, Shannxi, China
    The Second Affiliated Hospital of Air Force Medical University U
Sep 7, 2023

Advanced Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Recurrent Angioimmunoblastic T-Cell Lymphoma, Recurrent Grade 1

Active, not recruiting
  • Advanced Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
  • +18 more
  • Anti-ICOS Monoclonal Antibody MEDI-570
  • +2 more
  • Duarte, California
  • +22 more
Jan 18, 2023

Waldenstrom Macroglobulinemia, Multiple Myeloma, Chronic Lymphocytic Leukemia Trial in Worldwide (Iopofosine I 131 single dose,

Recruiting
  • Waldenstrom Macroglobulinemia
  • +8 more
  • Iopofosine I 131 single dose
  • +2 more
  • Redlands, California
  • +42 more
Dec 30, 2022

Mantle Cell Lymphoma Trial in United States (R-CHOP-14R-HIDAC,followed by RIT/HDT/ASCR.)

Active, not recruiting
  • Mantle Cell Lymphoma
  • R-CHOP-14R-HIDAC,followed by RIT/HDT/ASCR.
  • Basking Ridge, New Jersey
  • +4 more
Dec 1, 2022

NSCLC, Non-small Cell Carcinoma, NSCLC Stage I Trial (Stereotactic body radiotherapy, Hypofractionated radiotherapy, Durvalumab)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +4 more
  • Stereotactic body radiotherapy
  • +2 more
  • (no location specified)
Jul 5, 2022

Stage I NSCLC AJCC v7, Stage IA Non-Small Cell Lung Carcinoma AJCC v7, Stage IB Non-Small Cell Lung Carcinoma AJCC v7 Trial in

Recruiting
  • Stage I Non-Small Cell Lung Cancer AJCC v7
  • +6 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
May 2, 2022

Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type, Early Stage, Anlotinib Trial in Guangzhou (Sintilimab)

Completed
  • Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type
  • +7 more
  • Guangzhou, Guangdong, China
    Sun Yat-Sen University Cancer Center
Jun 6, 2022

Adult Grade III Lymphomatoid Granulomatosis, Cutaneous B-cell Non-Hodgkin Lymphoma, MALT Trial in Duarte (biological, procedure,

Active, not recruiting
  • Adult Grade III Lymphomatoid Granulomatosis
  • +23 more
  • autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Jan 4, 2023

Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial in Los Angeles (Autologous

Recruiting
  • Lung Non-Small Cell Carcinoma
  • +3 more
  • Autologous Dendritic Cell-Adenovirus CCL21 Vaccine
  • Pembrolizumab
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Jul 21, 2022

Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in Atlanta (Durvalumab,

Active, not recruiting
  • Lung Non-Small Cell Carcinoma
  • +9 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Aug 22, 2022

Grade 3a Follicular Lymphoma, Recurrent Follicular Lymphoma, Recurrent Grade 1 Follicular Lymphoma Trial in Houston (other,

Completed
  • Grade 3a Follicular Lymphoma
  • +9 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 31, 2023

Small Cell Lung Cancer Trial in Changsha (IBI-322 Plus Lenvatinib)

Not yet recruiting
  • Small Cell Lung Cancer
  • IBI-322 Plus Lenvatinib
  • Changsha, Hunan, China
    Hunan Cancer hospital
Jul 14, 2022

HIV Infection, Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Plasmablastic Lymphoma Trial in United States (procedure, drug,

Recruiting
  • HIV Infection
  • +10 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +7 more
  • La Jolla, California
  • +3 more
Dec 7, 2022

Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial in Houston

Recruiting
  • Recurrent Lung Non-Small Cell Carcinoma
  • +3 more
  • Durvalumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 10, 2022

NSCLC, Stage I Trial in United States (Pembrolizumab)

Recruiting
  • NSCLC, Stage I
  • Tampa, Florida
  • +10 more
Dec 12, 2022

Stage IIIA NSCLC Trial in Cleveland (Cisplatin, Etoposide, Pembrolizumab)

Terminated
  • Stage IIIA Non-Small Cell Lung Cancer
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Dec 15, 2022

Non Small Cell Lung Cancer, Stage I Lung Cancer, Stage Ib Lung Carcinoma Trial in Winston-Salem (Vitamin A Compound, Therapeutic

Active, not recruiting
  • Non Small Cell Lung Cancer
  • +5 more
  • Vitamin A Compound
  • Therapeutic Conventional Surgery
  • Winston-Salem, North Carolina
    Wake Forest Baptist Comprehensive Cancer Center
Jan 5, 2023

Contiguous Stage II Small Lymphocytic Lymphoma, Noncontiguous Stage II Small Lymphocytic Lymphoma, Prolymphocytic Leukemia Trial

Active, not recruiting
  • Contiguous Stage II Small Lymphocytic Lymphoma
  • +11 more
  • MOR00208
  • +2 more
  • Columbus, Ohio
    The Ohio State University Comprehensive Cancer Center
Feb 24, 2022

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Mantle Cell Lymphoma Trial in United States (TGR-1202, Ibrutinib)

Active, not recruiting
Has Results
  • Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
  • Mantle Cell Lymphoma
  • Monterey, California
  • +4 more
Aug 29, 2022

Lung Cancer, NSCLC Trial in Tampa (Vorinostat, Pembrolizumab)

Active, not recruiting
  • Lung Cancer
  • Non-small Cell Lung Cancer
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Nov 10, 2022

Small Cell Lung Cancer Extensive Stage Trial in Spain (Lenvatinib, Pembrolizumab, Etoposide)

Recruiting
  • Small Cell Lung Cancer Extensive Stage
  • Badalona, Barcelona, Spain
  • +17 more
Jan 26, 2023

Aggressive Non-Hodgkin Lymphoma, Indolent Non-Hodgkin Lymphoma, Recurrent DLBCL Trial in Rochester (procedure, biological,

Active, not recruiting
  • Aggressive Non-Hodgkin Lymphoma
  • +9 more
  • Cryosurgery
  • +5 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Aug 9, 2022